/
NEUROENDOCRINE APPETITE REGULATION: NOVEL WEIGHT LOSS STRATEGIES NEUROENDOCRINE APPETITE REGULATION: NOVEL WEIGHT LOSS STRATEGIES

NEUROENDOCRINE APPETITE REGULATION: NOVEL WEIGHT LOSS STRATEGIES - PowerPoint Presentation

alexa-scheidler
alexa-scheidler . @alexa-scheidler
Follow
371 views
Uploaded On 2018-03-20

NEUROENDOCRINE APPETITE REGULATION: NOVEL WEIGHT LOSS STRATEGIES - PPT Presentation

Prevalence of Adult Obesity 2000 to Present Clinical Disease Linked to Obesity Effect of Obesity on Healthrelated QualityofLife Effects of Obesity on Mortality Starting at Age 35 in Men Environmental Influences on ID: 658648

weight obesity appetite glp obesity weight glp appetite liraglutide management scale intake treatment regulating hormones pancreatic entero gastro body

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "NEUROENDOCRINE APPETITE REGULATION: NOVE..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

NEUROENDOCRINE APPETITE REGULATION: NOVEL WEIGHT LOSS STRATEGIESSlide2

Prevalence of Adult Obesity: 2000 to PresentSlide3

Clinical Disease Linked to ObesitySlide4

Effect of Obesity on Health-related Quality-of-LifeSlide5

Effects of Obesity on Mortality: Starting at Age 35 in MenSlide6

Environmental Influences on Body WeightSlide7

Gastro-Entero-Pancreatic Hormones Regulating Food Intake Slide8

Leptin, Adipose Tissue, and Body WeightSlide9

Gastro-Entero-Pancreatic Hormones Regulating Food Intake Slide10

GLP-1 Secretion in the Gut and Appetite Regulation Slide11

GLP-1 RA Treatment and Loss of Appetite: Lixisenatide vs LiraglutideSlide12

Bariatric Surgery and Hormone Changes in Ghrelin, PYY, and GLP-1 Slide13

Management of Obesity: Treatment ModalitiesSlide14

Liraglutide Approval for Weight ManagementSlide15

SCALE Obesity and Prediabetes: Effect of Liraglutide on Weight at 56 WeeksSlide16

EMA Approved Treatments for Weight ManagementSlide17

SCALE Obesity and Prediabetes: Weight Change DistributionSlide18

Abbreviations